| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SURVOPHTHAL.2012.10.006 |
| P698 | PubMed publication ID | 23253433 |
| P50 | author | Kostas G Boboridis | Q52349976 |
| Petros P Sfikakis | Q91233531 | ||
| Efstathios T Detorakis | Q125731710 | ||
| P2093 | author name string | Ioannis Mavrikakis | |
| Anita Chan | |||
| Sunny Shen | |||
| Andrea Low Hsiu Ling | |||
| P433 | issue | 3 | |
| P921 | main subject | rituximab | Q412323 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 252-265 | |
| P577 | publication date | 2012-12-17 | |
| P1433 | published in | Survey of Ophthalmology | Q7647088 |
| P1476 | title | B-cell targeted therapy with rituximab for thyroid eye disease: closer to the clinic | |
| P478 | volume | 58 |
| Q37106626 | Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy |
| Q44766839 | Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy. |
| Q37615281 | Rituximab Treatment in a Patient with Active Graves' Orbitopathy and Psoriasis |
| Q24202845 | Rituximab for thyroid-associated ophthalmopathy |
| Q28081573 | Rituximab in the Treatment of Thyroid Eye Disease: A Review |
| Q51220468 | The Efficacy of Rituximab Combined with 131I for Ophthalmic Outcomes of Graves' Ophthalmopathy Patients. |
Search more.